Harbin Gloria Pharmaceuticals Co (SZSE:002437) 3-Year EBITDA Growth Rate : -26.20% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co 3-Year EBITDA Growth Rate?

Harbin Gloria Pharmaceuticals Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.03.

During the past 3 years, the average EBITDA Per Share Growth Rate was -26.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Harbin Gloria Pharmaceuticals Co was 76.30% per year. The lowest was -26.20% per year. And the median was 1.00% per year.

Competitive Comparison of Harbin Gloria Pharmaceuticals Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Gloria Pharmaceuticals Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harbin Gloria Pharmaceuticals Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Gloria Pharmaceuticals Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Harbin Gloria Pharmaceuticals Co's 3-Year EBITDA Growth Rate falls into.

Harbin Gloria Pharmaceuticals Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Harbin Gloria Pharmaceuticals Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025

Website

http://www.gloria.cc

Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines